Peer Review History
| Original SubmissionJanuary 28, 2022 |
|---|
|
PONE-D-22-02786Identities of women who have an autoimmune rheumatic disease (ARD) during pregnancy planning, pregnancy and early parenting: A qualitative studyPLOS ONE Dear Dr. Williams, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The reviewers have raised a number of major concerns. They feel the manuscript should outline a clearly-defined research question, and they request improvements to the reporting of methodological aspects of the study. Could you please carefully revise the manuscript to address all comments raised? Please submit your revised manuscript by Oct 07 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Thomas Phillips, PhD Staff Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: I found this to be a very interesting paper that explores a lot of internal conflict experienced by women living with autoimmune rheumatic diseases. Although the topic of information needs and priorities of this population have been studied (and reproduced), I am not aware of any research on this particular research question and the emotional impact on patients and their families. I would ask that any results of literature reviews be clearly noted (briefly) in the introduction. I also offer the following suggestions and feedback for consideration by the study team: - I'm not sure I'm entirely comfortable with the "moral and good mother" reference. Although I think I understand what the writer is trying to get across, I wonder if there is a less stigmatizing word that could be used in its place. I believe the authors are trying to convey the norms, standards, etc. imposed by society on women which is indeed correct, but wonder if the current wording gets this idea across effectively to a perhaps less informed reader. - Did the study team consider how disability and systemic ableism might impact on often conflicting identities? There is a specific mention of physical disability later in the paper and I wonder if there can be a sentence or two of reflection about this phenomenon. I do not think that society's views of disability support women with ARD's in choosing motherhood or in being mothers. Perhaps elements of the socio-ecological approach could be helpful in this regard. I'd recommend a sentence of reflection in the discussion section. To me, the social vs medical model of disability has significant impacts on women with ARD's making reproductive health decisions. - I quite liked the flexible approach taken with the use of visual elements and 'resource pack' to help women share their experiences. Might it be possible to include what this looked like in an appendix? It might be of value to readers doing similar research. - I would remove "lived experiences" in quotations (line 144). It is merely a fact and way of explaining the keepers of the knowledge being sought. - I also really like how you all reflected on the personal roles and perspectives you took in collecting the data and that guided the analysis. - In the results section, I wonder if you might briefly explain how others shaped the identities taken on by women in a more direct way. This relates to how women are affected by societal norms and values including those of health care providers and whatever guidelines are in place (e.g. current recommendations - see ACR and EULAR that disease be well controlled). I'm not sure if researchers and health care providers necessarily see the unexpected consequences of their recommendations and clinical practice guidelines. - I wonder if it might be valuable to reflect on the role of policy makers in creating supportive policies, health care advice, and built environments that support mothers with ARD's including accessible programs. Perhaps a nice addition to the discussion section. - I really like the addition of SDM and patient preferences in the discussion section. Reviewer #2: The article is very relevant and interesting. Pregnancy in autoimmune rheumatic diseases is challenging and a person-centered approach is of paramount importance. This study helps identify ideas, themes, and difficulties persons have during their disease and their pregnancy or pregnancy planning. Qualitative study well carried out, good methodology, good writing and with value in its findings Consider adding the diagnoses of the ARDs that are included and the activity of the disease at the time of the interview. Include sociodemographic characteristics. The results may not be applicable to other populations. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Laurie Proulx Reviewer #2: Yes: Dionicio A. Galarza-Delgado, MD PhD ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Identities of women who have an autoimmune rheumatic disease (ARD) during pregnancy planning, pregnancy and early parenting: A qualitative study PONE-D-22-02786R1 Dear Dr. Williams, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Esmat Mehrabi Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .